HANDOK Inc.

Research HANDOK Inc. (002390.KS) on Bullrun: market cap KRW 108.73B, dividend yield 2.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 108.73B; dividend yield is 2.4%.

Peer valuation comparison

Latest dividend yield is 2.39% versus a Healthcare sector median of 2.4%.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 108.73Bn/a2.4%200

Dividend history

Latest trailing dividend snapshot: annual dividend/share 200 KRW, yield 2.4%.

About HANDOK Inc.

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition products.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is HANDOK Inc.'s market cap?

HANDOK Inc.'s market capitalization is KRW 108.73B.

Does HANDOK Inc. pay a dividend?

HANDOK Inc. has a dividend yield of 2.4%.

What does HANDOK Inc. do?

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition products. In addition, the company engages in real estate leasing.